1,470 results on '"MORBELLI, Silvia"'
Search Results
2. Mandatory role of endoplasmic reticulum and its pentose phosphate shunt in the myocardial defense mechanisms against the redox stress induced by anthracyclines
3. Mycoplasma hominis as Cause of Extragenital Infection in Patients with Hypogammaglobulinemia: Report of 2 Cases and Literature Review
4. Neuroimaging biomarkers in the biological definition of Parkinson’s disease and dementia with Lewy bodies – EANM position on current state, unmet needs and future perspectives
5. The Homunculus of unspecific bone uptakes associated with PSMA-targeted tracers: a systematic review-based definition
6. Automatic quantification of REM sleep without atonia reliably identifies patients with REM sleep behavior disorder: a possible screening tool?
7. Autoimmune encephalitis: what the radiologist needs to know.
8. Progression trajectories from prodromal to overt synucleinopathies: a longitudinal, multicentric brain [18F]FDG-PET study
9. Egesta Lopci, Luigi Mansi (editors). Advanced imaging and therapy in neuro-oncology, 1st edition. Springer, 2024. ISBN: 978-3-031-59340-6
10. Highlights of the 36th EANM Annual Congress 2023, from hometown Vienna, Austria: “A SYMPHONY OF SCIENCE”
11. EANM practice guidelines for an appropriate use of PET and SPECT for patients with epilepsy
12. Diagnostic performance of molecular imaging methods in predicting the progression from mild cognitive impairment to dementia: an updated systematic review
13. Diagnostic and prognostic value of dual-point amyloid PET in Alzheimer’s disease (AD) mimickers
14. Alzheimer’s disease (AD) co-pathology in dementia with Lewy bodies (DLB): implications in the disease modification era
15. Cerebrospinal fluid NPTX2 changes and relationship with regional brain metabolism metrics across mild cognitive impairment due to Alzheimer's disease
16. Perspectives of the European Association of Nuclear Medicine on the role of artificial intelligence (AI) in molecular brain imaging
17. Metabolic network alterations as a supportive biomarker in dementia with Lewy bodies with preserved dopamine transmission
18. Clinical and metabolic profiles in behavioural frontotemporal dementia: Impact of age at onset
19. EANM position paper: theranostics in brain tumours—the present and the future
20. Systemic inflammatory markers and volume of enhancing tissue on post-contrast T1w MRI images in differentiating true tumor progression from pseudoprogression in high-grade glioma
21. Amyloid PET Imaging: Standard Procedures and Semiquantification
22. Validation of the REM behaviour disorder phenoconversion-related pattern in an independent cohort
23. Sharing brain imaging data in the Open Science era: how and why?
24. Correction to: Highlights of the 36th EANM Annual Congress 2023, from hometown Vienna, Austria: “A SYMPHONY OF SCIENCE”
25. Apporto iodico e potenziali interferenze con le pratiche diagnostico-terapeutiche in ambito medico-nucleare
26. European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disorders
27. Subspace corrected relevance learning with application in neuroimaging
28. Neurological Disorders and Women's Health: Contribution of Molecular Neuroimaging Techniques
29. Superfluous, controversial and luxury issues in nuclear medicine
30. The diagnostic and prognostic role of combined [18F]FDG and [68Ga]-DOTA-peptides PET/CT in primary pulmonary carcinoids: a multicentric experience
31. Gene’s expression underpinning the divergent predictive value of [18F]F-fluorodeoxyglucose and prostate-specific membrane antigen positron emission tomography in primary prostate cancer: a bioinformatic and experimental study
32. Tracking the progression of Alzheimer's disease: Insights from metabolic patterns of SOMI stages
33. The prognostic value of FIGO staging defined by combining MRI and [18F]FDG PET/CT in patients with locally advanced cervical cancer
34. Combined forced diuresis and late acquisition on [68Ga]Ga-PSMA-11 PET/CT for biochemical recurrent prostate cancer: a clinical practice-oriented study
35. Different z-score cut-offs for striatal binding ratio (SBR) of DaT SPECT are needed to support the diagnosis of Parkinson’s Disease (PD) and dementia with Lewy bodies (DLB)
36. Case 33: Tumefactive Multiple Sclerosis Lesions (TMS)
37. Case 4: Parkinson’s Disease with Onset as Mild Cognitive Impairment (MCI)
38. Case 8: Multiple System Atrophy with DAT SPECT and [18F]FDG PET
39. Case 3: Alzheimer’s Disease—Behavioral Variant
40. Case 1: Mild Cognitive Impairment (MCI)—[18F]FDG and Amyloid PET
41. Case 13: Huntington’s Disease with Psychiatric Onset
42. Case 10: Progressive Supranuclear Palsy (PSP)
43. Case 12: Huntington’s Disease with Atypical Onset
44. Adopting transfer learning for neuroimaging: a comparative analysis with a custom 3D convolution neural network model
45. Time-dependent recovery of brain hypometabolism in neuro-COVID-19 patients
46. FDA approval of lecanemab: the real start of widespread amyloid PET use? — the EANM Neuroimaging Committee perspective
47. Right posterior hypometabolism in Pisa syndrome of Parkinson’s disease: A key to explain body schema perception deficit?
48. Intravenous immunoglobulin bridging to rituximab in NMDAR encephalitis patients non-responders to first-line treatments
49. A comparison of advanced semi-quantitative amyloid PET analysis methods
50. 2-[18F]-FDG PET for imaging brain involvement in patients with long COVID: perspective of the EANM Neuroimaging Committee
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.